Consider This from NPR The J & J Pause, Explained — And What It Means For The U.S. Vaccination Effort
Apr 13, 2021
A recommended pause on the Johnson & Johnson COVID vaccine has sparked discussions on vaccine safety and public confidence. Experts delve into the rare blood clot reports, weighing this against the need for vaccinations amid declining uptake. As misinformation spreads, strategies to combat vaccine hesitancy are crucial. The implications of this pause not only affect public trust but also highlight the ongoing challenges in the U.S. vaccination campaign, particularly as people are urged to continue supporting other vaccines.
AI Snips
Chapters
Transcript
Episode notes
J&J Vaccine Pause
- The CDC and FDA recommended a pause on the Johnson & Johnson COVID-19 vaccine.
- This is due to six reported cases of rare blood clots in over 6.85 million doses, a rate of less than one in a million.
Blood Clot Details
- Six women between 18 and 48 developed rare blood clots (CVST) after receiving the J&J vaccine.
- One woman died, and another is in critical condition; this type of clot needs different treatment than usual.
Vaccine Hesitancy
- The J&J pause comes as vaccine demand slows and hesitancy grows.
- Some areas are trying direct outreach, but nearly one-third of Americans are unsure or would refuse a vaccine.